Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative ...

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

Continuous Positive Airway Pressure (CPAP) machines are used to keep the airways open while someone sleeps. It's the gold ...

Abdominal fat mass index was strongly associated with obstructive sleep apnea risk across demographic subgroups, including racial and BMI categories.

Vivos Therapeutics announces positive clinical trial results for its DNA device treating obstructive sleep apnea in children.

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations ...

Learn the risk factors for obstructive sleep apnea, from obesity to fat deposits in the neck to certain medical conditions.

In December, GLP-1 agonist tirzepatide (Zepbound) became the first drug approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity after two trials showed it reduced ...

Vivos’ portfolio of cutting-edge oral appliances offer a proprietary, clinically effective OSA solution that is nonsurgical, noninvasive, and nonpharmaceutical, providing hope to allow patients to ...

You may not be getting quality sleep if you have sleep apnea fatigue. These tips can help you sleep better, reduce fatigue, and increase your energy.